Meta-analysis of the effectiveness of Chinese and Western integrative medicine on medium and advanced lung cancer

Objective

To summarize the effectiveness of Chinese and Western integrative medicine in treating medium and advanced lung cancer, and to provide guidelines for clinical application.

Methods

For this metaanalysis, a comparative search of Chinese medicine data in Chinese National Knowledge Infrastructure (CNKI) and Chinese BioMedical Literature Database (CBM) was undertaken to identify articles related to randomized comparative research of Chinese and Western integrative medicine in treating medium and advanced lung cancer between 1996 to 2006. Quality of life (QOL) was estimated using RevMan 4.2 software for data processing, adopting the odd ratio (OR) and the 95% confidence interval (CI).

Results

Through meta-analysis of 10 qualified articles, the results were as follows: the merging effectiveness of QOL OR=3.80, 95% CI (2.65, 5.47)]; the rate of survival OR=3.44, 95% CI (2.04, 5.80)]; the tumor response rate OR=1.88, 95% CI (1.37, 2.58)]; the tumor developing rate OR=0.33, 95% CI (0.23, 0.48)]. Significant differences existed between the Chinese and Western integrative medicine treatment group and the Western treatment group (P<0.01).

Conclusions

Chinese and Western integrative medicine treatment of medium and advanced lung cancer has shown to improve patients’ QOL and survival rate; it also can control tumor development in the short term.